Results 121 to 130 of about 243,193 (361)
, 2016 Neuromodulation is a new promising treatment for headache disorders. It consists of peripheral nerve neurostimulation and central neurostimulation. © 2016, Touch Briefings.
Silberstein, Stephen
core +2 more sources
Emerging Role of (Endo)Cannabinoids in Migraine [PDF]
, 2018 Pinja Leimuranta +2 more
openalex +1 more source
Epilepsia Open, EarlyView.Abstract Objective Status epilepticus (SE) is a neurological emergency requiring immediate treatment. Although intravenous lacosamide (LCM) is used for the management of epilepsy, its effectiveness in treating SE remains unclear. We aimed to compare the in‐hospital outcomes between intravenous LCM and levetiracetam (LEV) as an early adjunctive therapy ...
Yumiko Nakamura +8 more
wiley +1 more source
Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2). [PDF]
, 2019 BACKGROUND: Patients with high-frequency episodic migraine (HFEM) have a greater disease burden than those with low-frequency episodic migraine (LFEM).
Day, Katie A. +4 more
core +1 more source
Genes and primary headaches: discovering new potential therapeutic targets [PDF]
, 2013 Genetic studies have clearly shown that primary headaches (migraine, tension-type headache and cluster headache) are multifactorial disorders characterized by a complex interaction between different genes and environmental factors.
De Martino, Paola +8 more
core +3 more sources
CGRP and migraine: neurogenic inflammation revisited [PDF]
, 2005 Pierangelo Geppetti +5 more
openalex +1 more source
Acta clinica Croatica, 2010 Migraine is a primary recurrent headache manifesting in attacks lasting 4-72 hours and aff ects 2-20% of world population. Women are more often aff ected, mostly during reproductive years. Th e migraine effects quality of life and has negative impact on working capability.
openaire +3 more sources
The Journal of Pain, 2006 Pain aggravation by movement and avoidance of movement (kinesiophobia) is often reported by patients during migraine attacks. Yet its specific contribution to migraine diagnosis is undetermined. To characterize the frequency and severity of kinesiophobia during migraine and its role in the diagnosis of primary headaches, we questioned 150 patients (126
Martins, I, Gouveia, R, Parreira, E
openaire +3 more sources
Equine Veterinary Journal, EarlyView.Abstract Background Trigeminal‐mediated headshaking (TMHS) in horses shares clinical features with human trigeminal neuralgia (HTN). Increased levels of the neuropeptide calcitonin gene‐related peptide (CGRP) have been found in the blood and cerebrospinal fluid (CSF) of HTN patients. Inhibition of CGRP in humans has shown promise for pain relief.
Lisa Annabel Weber +7 more
wiley +1 more source
, 1999 Migraine is a complex neurovascular disease characterised by episodic attacks of severe headache accompanied by autonomic and neurological symptoms. Two types of migraine have been identified: (1) common migraine, or migraine without aura, occurring in ...
Farrugia, Isabelle
core